Genetic Disease Diagnostics Market
Genetic Disease Diagnostics Market Size, Share & Trend Analysis 2029
- Product Id: AIMR 1405
- Pages: 200
- Publish Date: May-2023
- Category: Life Sciences
Fill Details
Verify Email
Check your inbox for Sample + Methodology
Note: For delivery of sample pages you must have a Domain Specific EmailID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc are not accepted
Segments
By Type
- Pharmacogenomic Testing
- Prenatal & Neonatal Testing
- Carrier Testing
- Diagnostic Testing
- Predictive & Presymptomatic Testing
- Others
By Technology
- Biochemical Testing
- Cytogenic Testing
- Molecular Testing
- Others
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
- Abbott Laboratories Inc
-
Bio-Rad Laboratories, Inc
-
CSL Ltd
-
Danaher Corporation
-
Eurofins Scientific
-
F. Hoffman-LA Roche Ltd
-
Illumina, Inc
-
Qiagen N.V
-
Thermofisher Scientific, Inc
-
Myriad Genetics, Inc
-
Luminex Corporation
-
Biomereiux SA
-
Labcorp Corporation
-
deCODE genetics, Inc
-
BGI Group, Inc
+44-1173181773
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
LONDON OFFICE
AI® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
FOLLOW US
© Copyright 2025-26 AI® Market Research and Consulting. All Rights Reserved | Designed by AI® Market
